The Stanford Neuro-Oncology Program News and Events

News

‘Chemo brain’ caused by malfunction in three types of brain cells

Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.


Society for Neuro-oncology 2018

Reena Thomas, MD, PhD provides the daily highlight of clinical presentions for Sat Nov 17, 2018.


Medical students showcase research accomplishments

Guided by Reena Thomas, MD, PhD, clinical assistant professor of neurology and neurological sciences and of neurosurgery, second-year medical student Judith Pelpola investigated therapies to reduce the recurrence of glioblastoma.


Altered immune cells clear childhood brain tumor in mice

In mice, a fatal brainstem tumor was cleared by injecting it with engineered T cells that recognized the cancer and targeted it for destruction. The Stanford discovery is moving to human trials.

 


Events

The Riley Church Guest Professor

Scott Pomeroy, MD, PhD
Neurologist-in-Chief , Boston Children’s Hospital

"Heterogeneity of Molecular Mechanisms in Subgroups of Medulloblastoma”

Thursday November 29, 2018 at 1:00pm
Location: Lokey G1002

 

Cancer Biology Seminar Series

Mario Suva, MD, PhD
Harvard Medical School
Massachusetts General Hospital

"Dissecting Pediatric and Adult Gliomas by Single-cell Genomics"

March 5, 2019 •• 12-1pm
Location: Clark Center Auditorium

 

Grants and Awards

2018 NIH Director’s Pioneer Award

Michelle Monje, MD, PhD is a 2018 Awardee of the NIH Director’s Pioneer Award. The Pioneer Award supports individual scientists of exceptional creativity who propose highly innovative and potentially transformative approaches to major challenges in the biomedical or behavioral sciences towards the goal of enhancing human health. Dr. Monje received the award based on her laboratory research which discovered that neuronal activity critically regulates the progression of glial malignancies, and now seeks to leverage a deeper understanding of neuron-glioma interactions to develop novel therapeutic strategies for these lethal brain cancers.


Meetings

23rd ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY
OF THE SOCIETY FOR NEURO-ONCOLOGY

Marriott Hotel, New Orleans, Louisiana
Thursday, November 15 - Sunday, November 18, 2018

Stanford Brain Tumor Center reunion dinner at the Society for Neuro Oncology annual meeting in New Orleans 2018.